Structure Therapeutics (NASDAQ:GPCR) Price Target Lowered to $75.00 at HC Wainwright
Structure Therapeutics (NASDAQ:GPCR – Free Report) had its price target cut by HC Wainwright from $80.00 to $75.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently issued reports on GPCR. William Blair initiated coverage on shares of Structure Therapeutics […]
Structure Therapeutics (NASDAQ:GPCR – Free Report) had its price target cut by HC Wainwright from $80.00 to $75.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently issued reports on GPCR. William Blair initiated coverage on shares of Structure Therapeutics […]
